Novartis today disclosed plans to eliminate about 8,000 jobs worldwide as part of a cost-cutting effort intended to save the pharma giant at least $1 billion by 2024—part of a restructuring whose ...

Novartis is undertaking a huge restructuring to simplify its organization, and some of its employees will feel the pain. The company will cut thousands of jobs worldwide as part of a revamp unveiled ...

Novartis' 500 Swiss job cuts announced earlier this month are just the tip of a global iceberg. The company plans to cut or shuffle up to 4,000 jobs in its pharma business, with many of the positions ...

Novartis has announced plans to lay off 550 staff at its site in Stein, Switzerland, by the end of 2027. This follows the company’s call to shift towards “innovative manufacturing technologies”, which ...

Novartis will eliminate 1,630 sales rep jobs and 330 headquarters marketing jobs as its hypertension franchise faces the impending loss of Diovan patent exclusivity and the impact of ugly study ...

Novartis confirmed it will eliminate some 500 R&D positions companywide while adding 175 jobs in Cambridge, MA, where the pharma giant has its research headquarters. “This is not a pleasant decision ...

Novartis will close research operations in Switzerland and China, resulting in 175 job cuts, reports Reuters. The move represents an effort to lower costs and centralize control over the Basel, ...

ZURICH, June 28 (Reuters) - Novartis (NOVN.S), opens new tab said on Tuesday a previously announced restructuring programme could lead to 8,000 jobs being cut, or about 7.4% of its global workforce, ...

ZURICH, April 9 (Reuters) - Novartis (NOVN.S), opens new tab is to cut up to 680 jobs in its development organisation, which helps bring its drugs to market, the Swiss pharmaceuticals company said on ...

Swiss pharmaceutical giant Novartis AGNOVN1.35%increase; green up pointing triangle said it plans to shed as many as 8,000 jobs globally, including 1,400 in Switzerland, as part of a previously ...